Valink Therapeutics

Valink Therapeutics YC Application

Winter 2021Active

Valink Therapeutics went through Y Combinator in the Winter 2021 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Winter 2021
Industry
HealthcareTherapeutics
Team size
15
Status
Active
Launched
2021

Founders

  • Arne Scheu
    Arne ScheuFounder
  • Irsyad Khairil
    Irsyad KhairilFounder

What Valink Therapeutics does

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

Valink Therapeutics's YC application, reconstructed

Y Combinator application

Valink Therapeutics, Winter 2021 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Valink Therapeutics

Describe what your company does in 50 characters or less.

Discovering bispecific antibody drug-conjugates against cancer

What is your company going to make? Please describe your product and what it does or will do.

We're building a platform to discover bispecific antibody drug-conjugates (BsADCs) targeting solid tumors that current immunotherapies fail to address. Our approach combines multiple antibody modifications simultaneously - bi- and multispecificity, multivalency, and drug conjugation - within a single discovery process. This enables us to rapidly generate complex candidates with novel mechanisms of action.

Where do you live now, and where would the company be based after YC?

We live and work in Boston, MA, and we plan to keep the company based there after YC.

Explain your decision regarding location.

Boston is a top biotech hub with access to talent, labs, and partners critical to advancing antibody therapeutics. We want to be where the expertise and infrastructure are.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real Valink Therapeutics YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Valink Therapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Valink Therapeutics would present itself to YC, not the text they submitted.

What YC batch was Valink Therapeutics in?

Valink Therapeutics was part of the Y Combinator Winter 2021 batch.

Who founded Valink Therapeutics?

Valink Therapeutics was founded by Arne Scheu, Irsyad Khairil.

What does Valink Therapeutics do?

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Valink Therapeutics's application, and every other YC batch, is in YC Insights.

More YC startups like Valink Therapeutics